JP2021524866A5 - - Google Patents
Info
- Publication number
- JP2021524866A5 JP2021524866A5 JP2021514493A JP2021514493A JP2021524866A5 JP 2021524866 A5 JP2021524866 A5 JP 2021524866A5 JP 2021514493 A JP2021514493 A JP 2021514493A JP 2021514493 A JP2021514493 A JP 2021514493A JP 2021524866 A5 JP2021524866 A5 JP 2021524866A5
- Authority
- JP
- Japan
- Prior art keywords
- infection
- alkyl
- group
- compound
- pharmaceutical composition
- Prior art date
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1807966.5A GB201807966D0 (en) | 2018-05-16 | 2018-05-16 | Antibacterial compounds |
| GB1807966.5 | 2018-05-16 | ||
| GB1905174.7 | 2019-04-11 | ||
| GBGB1905174.7A GB201905174D0 (en) | 2019-04-11 | 2019-04-11 | Antibacterial compounds |
| PCT/GB2019/051349 WO2019220125A1 (en) | 2018-05-16 | 2019-05-16 | Antibacterial compounds |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021524866A JP2021524866A (ja) | 2021-09-16 |
| JPWO2019220125A5 JPWO2019220125A5 (https=) | 2022-05-20 |
| JP2021524866A5 true JP2021524866A5 (https=) | 2022-05-20 |
| JP7386853B2 JP7386853B2 (ja) | 2023-11-27 |
Family
ID=66641162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021514493A Active JP7386853B2 (ja) | 2018-05-16 | 2019-05-16 | 抗菌化合物 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11459296B2 (https=) |
| EP (1) | EP3793990B1 (https=) |
| JP (1) | JP7386853B2 (https=) |
| KR (1) | KR102807772B1 (https=) |
| CN (2) | CN118307515A (https=) |
| AU (1) | AU2019269544B2 (https=) |
| BR (1) | BR112020023155A2 (https=) |
| CA (1) | CA3098138A1 (https=) |
| ES (1) | ES2952981T3 (https=) |
| IL (1) | IL278571B2 (https=) |
| MX (1) | MX2020012263A (https=) |
| SG (1) | SG11202011298YA (https=) |
| WO (1) | WO2019220125A1 (https=) |
| ZA (1) | ZA202006612B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019269544B2 (en) | 2018-05-16 | 2024-03-21 | Infex Therapeutics Limited | Antibacterial compounds |
| GB201901559D0 (en) * | 2019-02-05 | 2019-03-27 | Syngenta Crop Protection Ag | Herbicidal compositions |
| GB201916915D0 (en) | 2019-11-20 | 2020-01-01 | Amr Centre Ltd | Compounds |
| GB202015885D0 (en) | 2020-10-07 | 2020-11-18 | Infex Therapeutics Ltd | Synthesis of pyrrole acid derivatives |
| GB2602096A (en) * | 2020-12-17 | 2022-06-22 | Infex Therapeutics Ltd | Compounds |
| IL314027B2 (en) | 2022-01-30 | 2025-04-01 | Xtend Ai Inc | Offline operation method of a smart, multi-purpose robot |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6143776A (en) * | 2000-02-02 | 2000-11-07 | Sunesis Pharmaceuticals, Inc. | Tosylproline analogs as thymidylate synthase inhibitors |
| CN1871248A (zh) * | 2003-08-21 | 2006-11-29 | 格里菲斯大学 | 新型次磺酰胺氧化物 |
| EP2511263A1 (en) * | 2011-04-14 | 2012-10-17 | Phenex Pharmaceuticals AG | Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases |
| TWI651300B (zh) | 2013-05-17 | 2019-02-21 | 健生科學愛爾蘭無限公司 | 胺磺醯基吡咯醯胺衍生物及其作為用於治療ｂ型肝炎藥物的用途 |
| GB201310542D0 (en) | 2013-06-13 | 2013-07-31 | Antabio Sas | Compounds |
| WO2015112441A1 (en) * | 2014-01-22 | 2015-07-30 | Merck Sharp & Dohme Corp. | Metallo-beta-lactamase inhibitors |
| CN107405333A (zh) * | 2015-02-27 | 2017-11-28 | 维颂公司 | 作为丝氨酸蛋白酶抑制剂的被取代的吡唑化合物 |
| WO2016187521A1 (en) | 2015-05-21 | 2016-11-24 | South Connecticut State University | 5-substituted 1 h-tetrazole compounds, methods of synthesizing and therapeutic use |
| GB201521059D0 (en) | 2015-11-30 | 2016-01-13 | Isis Innovation | Inhibitors of metallo-beta-lactamases |
| EP3272739A1 (en) | 2016-07-20 | 2018-01-24 | NodThera Limited | Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| GB201708457D0 (en) | 2017-05-26 | 2017-07-12 | Univ Oxford Innovation Ltd | Inhibitors of metallo-beta-lactamases |
| AU2019269544B2 (en) | 2018-05-16 | 2024-03-21 | Infex Therapeutics Limited | Antibacterial compounds |
| GB201916915D0 (en) * | 2019-11-20 | 2020-01-01 | Amr Centre Ltd | Compounds |
-
2019
- 2019-05-16 AU AU2019269544A patent/AU2019269544B2/en active Active
- 2019-05-16 CN CN202410414602.5A patent/CN118307515A/zh active Pending
- 2019-05-16 BR BR112020023155-0A patent/BR112020023155A2/pt active Search and Examination
- 2019-05-16 ES ES19726097T patent/ES2952981T3/es active Active
- 2019-05-16 CN CN201980048368.6A patent/CN112449638A/zh active Pending
- 2019-05-16 WO PCT/GB2019/051349 patent/WO2019220125A1/en not_active Ceased
- 2019-05-16 SG SG11202011298YA patent/SG11202011298YA/en unknown
- 2019-05-16 KR KR1020207035409A patent/KR102807772B1/ko active Active
- 2019-05-16 MX MX2020012263A patent/MX2020012263A/es unknown
- 2019-05-16 IL IL278571A patent/IL278571B2/en unknown
- 2019-05-16 JP JP2021514493A patent/JP7386853B2/ja active Active
- 2019-05-16 US US17/055,506 patent/US11459296B2/en active Active
- 2019-05-16 CA CA3098138A patent/CA3098138A1/en active Pending
- 2019-05-16 EP EP19726097.9A patent/EP3793990B1/en active Active
-
2020
- 2020-10-23 ZA ZA2020/06612A patent/ZA202006612B/en unknown
-
2022
- 2022-09-16 US US17/946,587 patent/US11845725B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021524866A5 (https=) | ||
| IL278571B2 (en) | Antibacterial compounds | |
| JP2013253094A5 (https=) | ||
| RU2015138796A (ru) | Способы и составы для лечения респираторных заболеваний | |
| HRP20190603T1 (hr) | 2-supstituirani spojevi cefema | |
| HRP20130928T1 (hr) | C7-fluor supstituirani spojevi tetraciklina | |
| US20260097011A1 (en) | Biofilm disruption | |
| CN107980000A (zh) | 包含抗菌剂的药物组合物 | |
| CN107847510A (zh) | 用于治疗细菌感染的组合物和方法 | |
| Kanj et al. | In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011 | |
| Loncar et al. | In vitro biofilm disruption and bacterial killing using nonantibiotic compounds against gram-negative equine uterine pathogens | |
| JP6480870B2 (ja) | 細菌感染を処置するための組成物および方法 | |
| JPWO2019220125A5 (https=) | ||
| DK2734203T3 (en) | A pharmaceutical composition for the treatment of a respiratory disease | |
| JP2008540515A (ja) | 嚢胞性線維症を含む重症感染症の処置および管理 | |
| JP5276653B2 (ja) | カルバペネム類を含む殺菌性抗ｍｒｓａ活性医薬組成物 | |
| JP2018521143A5 (https=) | ||
| JP2018109008A (ja) | 環状骨格ペプチドとの組合せ | |
| JP6525999B2 (ja) | 抗菌性組成物 | |
| CN106794250A (zh) | 包含抗菌剂的药物组合物 | |
| JP2016538262A (ja) | 抗菌剤を含む医薬品組成物 | |
| JPWO2021099793A5 (https=) | ||
| KR20160115941A (ko) | 항세균제를 포함하는 제약학적 조합 | |
| CN109568323B (zh) | 抗菌组合物及其用途 | |
| CN106163519A (zh) | 包含抗菌剂的药物组合物 |